Biotechnology Industry News

Merck says judge dismisses key case alleging Fosamax causes bone damage -- South Florida Sun-Sentinel.com

Sun-Sentinel (Fort Lauderdale, Fla.) | 19 minutes ago

WHITEHOUSE STATION, N.J. (AP) &#8212; Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction.... (more)

Latest Biotechnology Industry NewsMore >

BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz

TheStreet.com | 52 minutes ago

Novartis: 1st US plant for cell-based flu vaccine

CNBC | 1 hour 36 minutes ago

Readers ChoiceMore >

Vaccines become more attractive to drug developers

BIO SmartBrief | Nov 19, 2009

Sen. Reid's bill would add 6 months' protection for biotech drugs

BIO SmartBrief | Nov 23, 2009

Qiagen is prepared for more acquisitions, CFO says

BIO SmartBrief | Nov 18, 2009

Advanced Cell Technology seeks FDA clearance for stem cell trial

BIO SmartBrief | Nov 20, 2009

Onyx finalizes acquisition of Proteolix

BIO SmartBrief | Nov 17, 2009

BIO News More >

Grant-funding opportunities

BIO SmartBrief | Nov 23, 2009

Looking for new strategies for managing your company's cash flow during this economic lull?

BIO SmartBrief | Nov 20, 2009

Feeling the pinch in today's market hurts

BIO SmartBrief | Nov 19, 2009

Registration now open for 2010 BIO Asia Partnering Conference

BIO SmartBrief | Nov 18, 2009

Honolulu says "Aloha" to industrial biotechnology

BIO SmartBrief | Oct 30, 2009

Latest Biotechnology Industry Press ReleasesMore >

SHIRE PLC - Shire Submits European MAA for velaglucerase alfa

PRNewswire | 1 hour 6 minutes ago

Isis Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference

PRNewswire | 1 hour 6 minutes ago

Oxagen Limited Raises 16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds

Business Wire | 3 hours 36 minutes ago

Merck Wins Summary Judgment in Second Federal Bellwether Case Involving FOSAMAX (alendronate sodium)

Business Wire | 13 hours 6 minutes ago

Sign up for BIO SmartBrief

Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Subscribe to the BIO SmartBrief RSS feed

Publish your Press Release

Latest Blog Postsview more

New study finds MRSA on the rise in hospital outpatients
Science Blog

Metobolomics uncovers key indicators of nonalcoholic fatty liver disease
Science Blog

Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
Science Blog

Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later
Science Blog